PLN

Paul P. Dobesh, PharmD, FCCP, BCPS is an Associate Professor of Pharmacy Practice in the College of Pharmacy at the University of Nebraska Medical Center in Omaha, Nebraska. Dr. Dobesh is the Cardiology Section Coordinator for the Pharmacotherapy II course, and assists with the Drug Literature Evaluation and Research Methods course by leading discussions on literature evaluation. Additionally, Dr. Dobesh coordinates and serves as the primary preceptor for the Cardiology Clerkship. Dr. Dobesh received his Doctor of Pharmacy from South Dakota State University and completed an Internal Medicine Specialty Residency at the University of Texas/Brackenridge Hospital in Austin, Texas. Dr. Dobesh is responsible for teaching pharmacy and medical students and residents, and lectures in the areas of ischemic heart disease, antithrombotic therapy, and other cardiology and critical care topics. Dr. Dobesh has conducted research on antiplatelet and antithrombotic therapy, focusing on real-world utilization and health-economics.

Dr. Dobesh is a member of the University of Nebraska College of Pharmacy’s Pharmacy Practice Chair Advisory Committee and Admissions Committee, and is a journal reviewer for Annals of Pharmacotherapy, Pharmacotherapy, and Journal of Managed Care Pharmacy. He has also published book chapters and several manuscripts on the topics of antiplatelet and antithrombotic therapy.

Randolph V. Fugit, PharmD, BCPS is an Internal Medicine Clinical Specialist at the Denver Veterans Affairs Medical Center, as well as an Adjoint Assistant Professor in the Department of Pharmacy Practice in the College of Pharmacy at the University of Colorado Health Sciences Center in Denver, Colorado. Dr. Fugit received his Doctor of Pharmacy degree from the University of New Mexico, College of Pharmacy. Upon graduation, Dr. Fugit completed a clinical pharmacy practice residency at the Albuquerque Veterans Affairs Medical Center focusing on internal medicine, infectious diseases, and ambulatory care. Dr. Fugit’s areas of interest include pharmacoeconomics and outcomes research (including clinical pathway development) in the management of acute and chronic disease states in gastroenterology, infectious diseases, cardiology, and pulmonology.

Dr. Fugit is a board certified pharmacotherapy specialist and maintains an active clinical practice in the Department of Internal Medicine at the Denver Veterans Affairs Medical Center. He sits as an active member of the Colorado Multiple Institutional Review Board and performs peer review for several journals. Dr. Fugit also currently sits on the Colorado Clinical Guidelines Collaborative Committee and recently codeveloped the State of Colorado’s Guideline for Tobacco Cessation and Secondhand Smoke Exposure. He has published 2 book chapters and numerous peer-reviewed articles in the primary literature and has recently coauthored a chapter on Upper Gastrointestinal Disorders in Applied Therapeutics: The Clinical Use of Drugs.

Matthew Grissinger, RPh, FASCP is the Director of Error Reporting Programs at the Institute for Safe Medication Practices (ISMP). His responsibilities include working with healthcare practitioners and institutions to provide education about medication errors and their prevention, reviewing medication errors that have been voluntarily submitted by practitioners to a national United States Pharmacopeia/ISMP Medication Errors Reporting Program, as well as serving as a clinical analyst for the Pennsylvania Patient Safety Reporting System. Mr. Grissinger is also an Adjunct Assistant Professor at Temple University School of Pharmacy and Clinical Assistant Professor at the University of the Sciences in Philadelphia. Mr. Grissinger received his Bachelor of Science in Pharmacy from the Philadelphia College of Pharmacy and Science. Mr. Grissinger has extensive experience in long-term care, home care, and community pharmacy. Prior to joining ISMP, he served as a home care and long-term care pharmacy surveyor for the Joint Commission.

Mr. Grissinger is a fellow of the ISMP as well as the American Society of Consultant Pharmacists, and serves on the United States Pharmacopeia’s Safe Medication Use Expert Committee, the National Coordinating Council for Medication Error Reporting and Prevention, the Editorial Board for P&T Journal, and the Publications Advisory Board for Davis’s Drug Guide for Nurses. Mr. Grissinger is a frequent speaker on pharmacy topics and current issues in medication safety. He has published numerous articles in the pharmacy literature, including regular columns in P&T Journal, Pharmacy Today, and U.S. Pharmacist.

James S. Lewis II, PharmD is a clinical assistant professor in the College of Pharmacy & Department of Medicine – Division of Infectious Diseases at University of Texas at Austin in Austin, Texas and University of Texas Health Sciences Center at San Antonio in San Antonio, Texas. He is also Pharmacy Practice Residency Codirector at the University Health System in San Antonio, Texas, and Codirector of the Infectious Diseases Pharmacotherapy Specialty Residency in the South Texas Veterans Healthcare System and University Health System in San Antonio, Texas. In addition, Dr. Lewis serves as the Infectious Diseases Pharmacy Programs Manager and Infectious Diseases Clinical Pharmacy Specialist at the University Hospital in San Antonio, Texas, where his responsibilities include development and implementation of policy related to anti-infective therapy. Dr. Lewis received his Doctor of Pharmacy (cum laude) from Washington State University, then completed a Pharmacy Practice Residency at Southwest Washington Medical Center in Vancouver, Washington, and an Infectious Diseases Pharmacotherapy Specialty Residency at the University of Texas Health Sciences Center at San Antonio and South Texas Veterans Health Care System. He is a licensed pharmacist in Texas and Washington and has held several teaching positions in infectious diseases pharmacology. Dr. Lewis currently serves as coprinciple investigator and costudy coordinator for clinical trials involving systemic antifungal agents.

Dr. Lewis is a member of several professional societies, including the American College of Clinical Pharmacy, the Infectious Diseases Society of America, the American Society for Microbiology, the Society of Infectious Diseases Pharmacists, and the Texas Infectious Diseases Society. He has served as reviewer for several infectious diseases journals, as well as for the Journal of the American Medical Association. In 2006, he received an award from the Society of Infectious Diseases Pharmacists for Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy. Dr. Lewis is the coauthor of numerous published articles and abstracts, including many focusing on antimicrobial resistance and the pharmacology of antifungal agents. His clinical research experience includes development of interpretive breakpoint criteria for susceptibility tests for Neisseria meningitidis and phase 3 clinical trials evaluating the safety and efficacy of antifungal agents in invasive candidiasis.

Robert P. Rapp, PharmD, FCCP is an Emeritus Professor of Pharmacy in the College of Pharmacy and Professor of Surgery in the College of Medicine at the University of Kentucky in Lexington, Kentucky. Dr. Rapp also served as Associate for Clinical Services in the Department of Pharmacy Services in University Hospital in Lexington, Kentucky. At the University of Kentucky College of Pharmacy, Dr. Rapp educated pharmacy students in microbiology, infectious disease pharmacotherapy, and served as the preceptor in infectious disease for both residents and students.

Dr. Rapp is a member of the American Society of Microbiology, the Society of Infectious Disease Pharmacists, the American Society of Health Systems Pharmacy, the American College of Clinical Pharmacy, and the Society for Hospital Epidemiology. He is also a Fellow of the American College of Clinical Pharmacy. Dr. Rapp currently serves on the Editorial Board of the Annals of Pharmacotherapy, and as a reviewer for the American Journal of Health Systems Pharmacy, Pharmacotherapy, Journal of the Joint Commission on Hospital Accreditation, Journal of Antimicrobial Chemotherapy, and Clinical Infectious Diseases, among other publications. During his academic career, Dr. Rapp has published more than 225 papers in the professional and scientific literature and has been the author of numerous text book chapters in infectious disease and microbiology. Dr. Rapp received the Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy from the American College of Clinical Pharmacy in 2008.

William J. Cardarelli, PharmD is Director of Pharmacy for Atrius Health and Harvard Vanguard Medical Associates in Boston, Massachusetts. In his current position, Dr. Cardarelli is responsible for all pharmacy services in a 30-site integrated delivery system serving more than 800,000 patients. These services include the operation of 14 staff-model pharmacies, central pharmacy administration, and an extensive clinical pharmacy program. He is also responsible for the total pharmacy spend budget which exceeds $200 million dollars annually. In addition, Dr. Cardarelli continues his academic responsibilities as the principal manager of the American Society of Health System Pharmacists-certified Managed Care Pharmacy Residency in collaboration with the Massachusetts College of Pharmacy. Dr. Cardarelli earned a Bachelor of Arts at the University of Massachusetts and earned both his Bachelor of Science in Pharmacy and Doctor of Pharmacy from Massachusetts College of Pharmacy. He completed his postgraduate residencies in pharmacy at Peter Brigham Hospital in Boston, Massachusetts and Newton Wellesley Hospital in Newton, Massachusetts.

An experienced pharmacy administrator for more than 20 years, Dr. Cardarelli has a large breadth of experience in cost containment and resource allocation in the managed care arena. He has held progressive management responsibilities at Harvard Community Health Plan, Harvard Pilgrim Health Care, and Harvard Vanguard Medical Associates. Dr. Cardarelli is a member of the Academy of Managed Care Pharmacy, the American Society of Health System Pharmacists, and the Massachusetts Pharmacists Association. In 2004, Dr. Cardarelli received the Harvard Vanguard Clinical Innovation Award for his efforts in clinical innovation and improving patient health.